Combined inhibition of β-catenin and Bcr–Abl synergistically targets tyrosine kinase inhibitor-resistant blast crisis chronic myeloid leukemia blasts and progenitors in vitro and i...

por Zhou, H, Mak, P Y, Mu, H, Mak, D H, Zeng, Z, Cortes, J, Liu, Q, Andreeff, M, Carter, B Z
Publicado 2017